Document is current
Any future updates will be listed below
-
Authors
Ichikawa, Takaya
Hiono, Takahiro
Okamatsu, Masatoshi
Maruyama, Junki
Kobayashi, Daiki
Matsuno, Keita
Kida, Hiroshi
Sakoda, Yoshihiro https://orcid.org/0000-0001-7021-1688
-
Funding
Funding for this research was provided by:
Japan Agency for Medical Research and Development (JP233fa627005)
Japan Agency for Medical Research and Development (JP23jm0110019)
Japan Agency for Medical Research and Development (JP18fm0208026)
Japan Agency for Medical Research and Development (JP18fm0108008)
Japan Science and Technology Agency (JPMJSP2119)
Ministry of Education, Culture, Sports, Science and Technology (1801)
Japan Society for the Promotion of Science (JP23KJ0059)
- License Information
-
More Information
Article History
Received: 25 March 2024
Accepted: 16 July 2024
First Online: 22 September 2024
Declarations
:
: The authors declare that they have no competing interests.
: Animal experiments were approved by the Institutional Animal Care and Use Committee of the Faculty of Veterinary Medicine, Hokkaido University (approval numbers: 13-0108, 13-0162, 18-0037, and 18-0040). All experiments involving genetically modified organisms, including mutant viruses generated by reverse genetics, were authorized by the Safety Committee on Genetic Recombination Experiments of Hokkaido University (approval numbers: 2015-019 and 2020-009) and the Ministry of Education, Culture, Sports, Science, and Technology, Japan (30-963, 2-654). This study was approved by the Biosafety Management Committee on Pathogens and Other Hazardous Agents of the Faculty of Veterinary Medicine, Hokkaido University (approval numbers: 2017-1-61, 2018-1-59, and 2019-1-62).
